Study: Breast imaging with contrast agents needs blood flow monitoring

01/23/2014 | HealthImaging.com

A new study suggests that breast imaging protocols that incorporate injected contrast agents should include monitoring of changes in blood flow caused by mammographic compression, as compression significantly reduces contrast and may affect imaging outcomes. Using diffuse optical and diffuse correlation spectroscopies, researchers noted reductions in total hemoglobin content and blood flow under pressure in 15 healthy patients, according to the study published in Academic Radiology.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD